Your browser doesn't support javascript.
loading
Understanding Variation in Rotavirus Vaccine Effectiveness Estimates in the United States: The Role of Rotavirus Activity and Diagnostic Misclassification.
Amin, Avnika B; Lash, Timothy L; Tate, Jacqueline E; Waller, Lance A; Wikswo, Mary E; Parashar, Umesh D; Stewart, Laura S; Chappell, James D; Halasa, Natasha B; Williams, John V; Michaels, Marian G; Hickey, Robert W; Klein, Eileen J; Englund, Janet A; Weinberg, Geoffrey A; Szilagyi, Peter G; Staat, Mary Allen; McNeal, Monica M; Boom, Julie A; Sahni, Leila C; Selvarangan, Rangaraj; Harrison, Christopher J; Moffatt, Mary E; Schuster, Jennifer E; Pahud, Barbara A; Weddle, Gina M; Azimi, Parvin H; Johnston, Samantha H; Payne, Daniel C; Bowen, Michael D; Lopman, Benjamin A.
Afiliación
  • Amin AB; From the Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.
  • Lash TL; From the Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.
  • Tate JE; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA.
  • Waller LA; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA.
  • Wikswo ME; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA.
  • Parashar UD; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA.
  • Stewart LS; Department of Pediatrics, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN.
  • Chappell JD; Department of Pediatrics, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN.
  • Halasa NB; Department of Pediatrics, Division of Infectious Diseases, Vanderbilt University Medical Center, Nashville, TN.
  • Williams JV; Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.
  • Michaels MG; Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.
  • Hickey RW; Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA.
  • Klein EJ; Department of Pediatrics, Seattle Children's Research Institute, Seattle Children's Hospital and the University of Washington, Seattle, WA.
  • Englund JA; Department of Pediatrics, Seattle Children's Research Institute, Seattle Children's Hospital and the University of Washington, Seattle, WA.
  • Weinberg GA; University of Rochester School of Medicine and Dentistry, Rochester, NY.
  • Szilagyi PG; University of Rochester School of Medicine and Dentistry, Rochester, NY.
  • Staat MA; University of California at Los Angeles, Los Angeles, CA.
  • McNeal MM; Department of Pediatrics, University of Cincinnati, Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Boom JA; Department of Pediatrics, University of Cincinnati, Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
  • Sahni LC; Department of Pediatrics, Baylor College of Medicine, Houston, TX.
  • Selvarangan R; Texas Children's Hospital, Houston, TX.
  • Harrison CJ; Department of Pediatrics, Baylor College of Medicine, Houston, TX.
  • Moffatt ME; Texas Children's Hospital, Houston, TX.
  • Schuster JE; Children's Mercy-Kansas City, Kansas City, MO.
  • Pahud BA; Children's Mercy-Kansas City, Kansas City, MO.
  • Weddle GM; Children's Mercy-Kansas City, Kansas City, MO.
  • Azimi PH; Children's Mercy-Kansas City, Kansas City, MO.
  • Johnston SH; Children's Mercy-Kansas City, Kansas City, MO.
  • Payne DC; Children's Mercy-Kansas City, Kansas City, MO.
  • Bowen MD; University of California-San Francisco Benioff Children's Hospital Oakland, Oakland, CA.
  • Lopman BA; University of California-San Francisco Benioff Children's Hospital Oakland, Oakland, CA.
Epidemiology ; 33(5): 660-668, 2022 09 01.
Article en En | MEDLINE | ID: mdl-35583516
BACKGROUND: Estimates of rotavirus vaccine effectiveness (VE) in the United States appear higher in years with more rotavirus activity. We hypothesized rotavirus VE is constant over time but appears to vary as a function of temporal variation in local rotavirus cases and/or misclassified diagnoses. METHODS: We analyzed 6 years of data from eight US surveillance sites on 8- to 59-month olds with acute gastroenteritis symptoms. Children's stool samples were tested via enzyme immunoassay (EIA); rotavirus-positive results were confirmed with molecular testing at the US Centers for Disease Control and Prevention. We defined rotavirus gastroenteritis cases by either positive on-site EIA results alone or positive EIA with Centers for Disease Control and Prevention confirmation. For each case definition, we estimated VE against any rotavirus gastroenteritis, moderate-to-severe disease, and hospitalization using two mixed-effect regression models: the first including year plus a year-vaccination interaction, and the second including the annual percent of rotavirus-positive tests plus a percent positive-vaccination interaction. We used multiple overimputation to bias-adjust for misclassification of cases defined by positive EIA alone. RESULTS: Estimates of annual rotavirus VE against all outcomes fluctuated temporally, particularly when we defined cases by on-site EIA alone and used a year-vaccination interaction. Use of confirmatory testing to define cases reduced, but did not eliminate, fluctuations. Temporal fluctuations in VE estimates further attenuated when we used a percent positive-vaccination interaction. Fluctuations persisted until bias-adjustment for diagnostic misclassification. CONCLUSIONS: Both controlling for time-varying rotavirus activity and bias-adjusting for diagnostic misclassification are critical for estimating the most valid annual rotavirus VE.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por Rotavirus / Rotavirus / Vacunas contra Rotavirus / Gastroenteritis Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Child / Humans / Infant País/Región como asunto: America do norte Idioma: En Revista: Epidemiology Asunto de la revista: EPIDEMIOLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por Rotavirus / Rotavirus / Vacunas contra Rotavirus / Gastroenteritis Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Child / Humans / Infant País/Región como asunto: America do norte Idioma: En Revista: Epidemiology Asunto de la revista: EPIDEMIOLOGIA Año: 2022 Tipo del documento: Article